We have investigated the question of erythropoietin (Epo) hypersensitivity versus Epo independence as the basis for the endogenous erythroid bursts (EEBs) that develop in cultures without added Epo from hematopoietic cells of polycythemia vera (PV) patients. Using an improved serum-free (SF) medium containing interleukin (IL)-3, but no insulinlike growth factor-l (IGF-l), and devoid of contaminants that influence erythropoiesis, we compared circulating normal and PV early erythroid progenitors (BFU-E) with respect to their responses in vitro to recombinant human (rHu) Epo. Cultures were seeded with Ficoll-Hypaque density-separated peripheral blood (PS) mononuclear cells (MNCs), and erythroid bursts, together with their component colonies of 250 cells, were scored in situ at 13 to 1 6 days of culture. The Epo dose-response curve of BFU-E from PV patients was found to be statistically indistinguishable from that of normal subjects. This observation OLYCYTHEMIA RUBRA VERA (PV) is a chronic myeloproliferative disorder of unknown etiology, characterized by deregulated clonal proliferation of a pluripotential stem cell' and leading to hyperplasia in all three major myeloid lineages (with consequent granulocytosis, thrombocytosis, and erythrocytosis), but with the most pronounced effects being seen in the erythroid lineage. Patients with this disorder exhibit an increased red blood cell (RBC) mass with or without splenomegaly, in the presence of normal O2 saturation.2 The overproduction of RBCs is frequently associated with depressed serum and urinary levels of erythropoietin ( E~o ) .~-~ Hence, unlike other polycythemias, the erythrocytosis in PV cannot be attributed to an oversecretion of Epo in response to tissue hypoxia.
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In 1975, Prchal and Axelrad, using the plasma culture system, showed that PV bone marrow (BM) cells could generate late, colony-forming unit-erythroid (CFU-E)-derived erythroid colonies in vitro in the absence of added E~o .~ These colonies became known as endogenous erythroid colonies (EECs). Subsequently, production of endogenous erythroid bursts (EEBs) in the absence of added Epo by early erythroid progenitors (BFU-E) from BM or peripheral blood (PB) of PV patients was also rep~rted."~ To explain the production of EECs and EEBs observed in PV, two major hypotheses have been proposed. 6 The first, or Epo-hypersensitivity hypothesis, suggested that EECs in PV arose from Epo-hypersensitive erythroid progenitors responding to the minute quantities of Epo that were believed to be present in the fetal calf serum (FCS) used in the culture m e d i~m .~.~-' ' The second, or Epo-independence hypothesis, attributed EEC production to an autonomous process that did not require the participation of E~o . " -'~ Various groups of investigators have obtained contradictory evidence in favor of each of these models.
All of these studies were performed in serum-containing (SC) or serum-depleted (SD), so-called serum-free (SF), culture systems. However, undefined factors in serum and con- provides compelling evidence against the Epo-hypersensitivity hypothesis. In the complete SF medium minus Epo, the sensitivity of BFU-E to IGF-l was much greater in PV than in normals, the dose-response curve being shifted to the left by at least 2 orders of magnitude. These data show that the erythroid progenitor cell response in PV is hypersensitive to IGF-1, and independent of Epo. The data also emphasize the importance of truly SF medium conditions for assessment of progenitor cell sensitivities to recombinant growth factors. Depletion of adherent cells totally prevented erythroid burst formation by normal circulating progenitors, but did not prevent the hypersensitive response to IGF-1 of such cells from PV patients. Hence, again unlike its normal counterpart, the progenitor cell response in PV appears to be independent of adherent cell control. taminants in nondelipidated albumin and in other partially purified preparations such as Epo have all been shown to affect erythropoiesis. '6-22 Therefore, these assay systems could not provide reliable measures of the sensitivities of normal or PV erythroid progenitor cells to specific growth factors, even if recombinant molecules were being tested. Moreover, our reading of the literature suggested another explanation for the contradictory findings. The experiments that led to the Epo-independence interpretation ofthe EEC/ EEB phenomenon had all used media containing high levels of i n s~l i n , ' " '~ whereas those experiments that suggested instead the Epo-hypersensitivity interpretation had used media that lacked insulin,739-" suggesting the possibility that insulin (or insulin-like growth factors [IGFs] ) might be implicated in EEC formation in PV. This view appeared to be further strengthened by reports that the Epo-like activity in FCS could be abrogated by an anti-IGF-1 antibody,23 that insulin and IGF-I and -2 enhanced both erythroid colony and erythroid burst f o r m a t i~n , '~*~~-~~ and that nondelipidated albumins, major constituents of the culture media 100 used, were heavily contaminated with peptides of the IGF family.21. 22 We have recently reported the development of an improved SF medium that contains no contaminants that have burst-promoting activities (BPA) or Epo-like activities, and uses a defatted albumin.29 Defatted albumin is deprived of both lipids and a variety of small molecules, either or both of which may be responsible for the erythropoietic activity known to be associated with nondelipidated albumin. 16 When this basal SF medium is supplemented with optimal concentrations of the peptide growth factors recombinant human (rHu) interleukin (1L)-3, and rHu Epo or rHu IGF-1, together with hemin and retinoids, it supports the viability and efficient proliferation and differentiation of circulating erythroid progenitors from adult human PB. To our knowledge, this is the first SF medium for the growth of human PB BFU-E that makes use of a BPA-free albumin. We report here the results of using this medium to investigate the sensitivities of normal and PV PB erythroid progenitor cells to the recombinant growth factors rHu Epo and rHu IGF-1. We found that the endogenous bursts and colonies characteristic of PV are not due to hypersensitivity of erythroid progenitors to Epo, but rather to their hypersensitivity to IGF-1. Furthermore, the growth of PV PB BFU-E, unlike that of their normal counterparts, appeared to be independent of adherent cell activity.
MATERIALS AND METHODS

Patients
Positive selection of PV patients followed the standard guidelines established by the PV Study Group': the three major criteria were increased total RBC mass (>35 mL/kg) and splenomegaly in the presence of normal 0 ' saturation (292%). In the absence of one of the major criteria, a diagnosis of PV was made if there was a combination of two of the following four minor criteria: (1) increased platelet count (>400 X 109/L), (2) increased white blood cell count (> 12 X 109/L), (3) increased neutrophil alkaline phosphatase score (> 120), and (4) increased serum BIZ (>700 pmol/L). Clinical data on eight PV patients are listed in Table 1 . All patients were being managed by phlebotomy at the time of study, but no patient had undergone phlebotomy within the preceding 4 weeks, or had recently received chemotherapy.
Cell Preparations
After informed consent was obtained, PB was obtained by venipuncture from healthy volunteer donors and PV patients, and was immediately placed in a-minimal essential medium ((U-MEM) containing 2% FCS (#SP802 19; GIBCO, Grand Island, NY) and 10 U/ mL of preservative-free sodium heparin (#S20 5077MF; GIBCO).
Mononuclear cells (MNC) were separated by Ficoll-Hypaque (Pharmacia, Montreal, Canada) density-gradient centrifugation at 400g for 40 minutes. Cell suspensions were washed three times (400g, 10 minutes), the first wash in the presence of 2% FCS plus (U-MEM, and the subsequent two washes in a-MEM alone. Cell counts were made with the Trypan Blue(0.4%, #630-5250; GIBCO) dye-exclusion method. 
Anti-IGF-l Receptor Monoclonal Antibody
Monoclonal mouse IgG anti-type I IGF-I receptor antibody (~d R -3 )~~ was purchased from Oncogene Science, Manhasset, NY (#GRI l).
Clonal Cell Culture
SF culture of PB MNC was performed in flat-bottomed ( 1 .S X 1 .O cm) plastic wells (#76-000-04, Flow Laboratories, MacLean, VA, now discontinued; Nunclon Delta SI 24-well multidishes #l-43982, A/S Nunc, Roskilde, Denmark; were also used). The SF culture method has been previously de~cribed.~' Between 5 X IO4 and 1 X IO' PB MNC were plated in 0.5 mL of final culture medium containing a-MEM, 0.8% of 1,500-centipoise methylcellulose (Methocel A4M, premium grade; Dow Chemical, Midland, MI), I% fatty acid-and globulin-free crystallized bovine serum albumin (BSA; Sigma, St Louis, MO), which was deionized with analytical-grade ion exchange resin (AG 50 1 -X8 D, BioRad Labs, Richmond, CA), 2 X I 0-4 mol/L p-mercaptoethanol (BDH Biochemicals, Poole, England), 270 pg/mL fully iron-saturated human transfemn (T2252; Sigma), 7 X IO" mol/L D-a-tocopherol (Clinic Products, Windsor, Canada), 3 X lo-* mol/L retinyl acetate (Nutritional Biochemicals, Cleveland, OH), 8 &mL L-a-phosphatidyl choline dipalmitoyl synthetic (Sigma), 5.6 pdmL porcine liver cholesterol, grade 1 (Sigma), IO pg/mL ofeach ofthe four nucleosides(Sigma), 2 mmol/ L L-glutamine (Sigma), 100 U/mL penicillin G, and 50 pg/mL streptomycin sulfate (GIBCO), plus combinations of several growth factors at the indicated concentrations. The Petri dishes containing the wells were incubated at 37°C in a humidified atmosphere and 5% CO2 for I3 to 16 days.
Recombinant and Other Growth Factors
Escherichia coli-derived rHu somatomedin-C (referred to as rHu IGF-1) having the natural amino acid sequence was purchased from Amersham, Oakville, Canada. rHu Epo and rHu IL-3 were generous gifts from AMGen, Thousand Oaks, CA, courtesy of Dr J. Egrie. Bovine type 1 hemin (ferric chloride protoporphyrin IX) was purchased from Sigma (no. H-2250), with approximately 97% purity by spectrophotometric assay. The final concentrations of these growth factors used in the optimal medium were as follows: 30 to 100 nmol/L rHu IGF-I, 0.9 to 1.8 nmol/L (3.0 to 6.0 U/mL) rHu Epo, 0.2 to 0.8 nmol/L rHu IL-3, and 0.1 or 0.25 mmol/L hemin.
Scoring of Erythroid Bursts and Burst-Component Colonies
All erythroid bursts and colonies were scored by in situ observation with an inverted microscope, in most instances on the basis of their red color and characteristic colony morphology; in a few experiments, acid benzidine staining" was performed in situ, if the hemoglobinization of the colonies was not readily apparent. Benzidine stain was never used when hemin was included in the medium.
The progeny of a single BFU-E appear either as a single colony or as a group of colonies developing in the same neighborhood. Since nothing defines the dimensions of the neighborhood, we cannot know where its limits lie. Accordingly, we are forced to score these entities arbitrarily. This problem becomes the more critical as the density of burst growth is greater, whether by increased cell numbers plated or by improved culture conditions. Moreover, other factors such as viscosity of the medium and duration of culture have a profound influence on the numbers scored as they alter the density of bursts per unit area. Some investigators report that bursts are composed of three or more subcolonies, irrespective of subcolony cell~larity,~~ others count bursts as one or more clusters of 50 or more benzidine-positive cells or alternatively, three or more aggregates of IO to 49 such cells,I7 while still others appear to count subcolonies as bursts.14." Some investigators distinguish between small (fewer than eight subcolonies) and large (more than eight subcolonies) bursts at day 14, and wrongly name these, respectively, mature and primitive bursts.34 Furthermore, there are also discrepancies in the total number of cells per burst (and, implicitly, per subcolony) according to the cellularity cut-off point used. A burst may have as few as 50 cells,17 or IOO? or 500,'' and averages of 100: 100 to 1,000,33~36 500 to 1,000,37 or 5,7003* hemoglobinized cells. With the exception of Eaves' group," all of the studies referred to score bursts at days 12 to 14. It is apparent that there is little agreement in the literature on morphological and cellularity criteria used to score bursts and their component colonies.
We have described erythroid bursts and burst-component colonies (BCCs) that develop in our improved SF medium?' An erythroid burst is defined as either a single colony or a cluster of BCCs, each having 50 or more hemoglobinized cells, scored at days 13 to 16 of growth. Even though hemoglobinized colonies with fewer than 50 cells could also be observed, and often appeared to belong to a burst, their counts were not included unless two or more ofsuch colonies were contiguous. BCCs, also referred to as day 14 colonies or subcolonies, were easy to count and their numbers could be considered reliable even when crowding of the cultures made the distinction between individual bursts questionable. We have scored both bursts and BCCs because of our previous observation that their responses to culture conditions are not necessarily identi~al.~'
Immunological IdentiJcation of Erythroid Cells in Bursts
Indirect immunofluorescence experiments were performed on cytospin preparations of dissociated cells from day I3 SF cultures of Ficoll-Isopaque-isolated PB MNC from a patient with PV or appropriate normal controls. The slides were fixed in absolute methanol, coated with 0.5% BSA, and reacted with primary and/or secondary antibody. The primary antibody was a monoclonal mouse antihuman p-globin (37-8)40 kindly provided by Dr Thalia Papayannopoulou, Department of Medicine, University of Washington, Seattle, WA. The secondary antibody was a goat anti-mouse IgG F(ab'), fragment, affinity-purified, and fluorescein isothiocyanate ( 
Statistical Analysis
The mean ~f -SEM of the number of bursts and BCCs for each of three or six dishes was calculated. Data sets were compared by Student's two-tailed t test. Linear regression curves (0.95 confidence level) and curve smoothing (distance weighted least squares) were determined with a SYSTAT 5.0 software program (SYSTAT, Evanston, IL).
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From Fig 1) yielded significantly higher numbers of erythroid bursts than did Epo, with or without RA (bars 3 and 4, Fig 1) or than did IGF-l in the absence of RA (bar 5, Fig 1) . Overall, the mean number of bursts obtained with PV PB MNC was 145 per IO5 MNC. Addition of Epo to IGF-I, with or without RA and in the presence of IL-3 and hemin (bars 7 and 8, Fig l) , showed that the Epo and IGF-l effects were not additive (compare with Correa and Axelrad2'). Last, the addition of 10% FCS indicated that, like IGF-l (bars 5 and 1 , Fig l ) , though not as eficiently, serum could promote endogenous burst formation in the absence of Epo (bar 9, Fig I) .
Examination of the effects of different growth factor combinations on the formation of bursts and BCCs produced by the PB MNC of a third PV patient confirmed the nonadditive re-CORREA, ESKINAZI, AND AXELRAD lationship observed between Epo and IGF-I for both bursts and their component colonies (bar 5 v bars 6 and 7, Fig 2) , and showed that it was still valid when IL-3 was subtracted from the medium (bar 4 v bars 1 and 3, Fig 2) . By itself, the hemin concentration of 0.25 mmol/L provided enough BPA for the production of bursts in SF medium. The results also indicated that hemin was responsible for half of the total number of bursts and their component colonies observed in the complete medium (bars 1 to 4 v 5 to 7, Fig 2) . The addition of IGF-I alone to hemin was enough for bursts to be detected in situ by their hemoglobinization, in the absence of any retinoids (bar Fig 2) . Moreover, the addition of either RA or all-truns-retinoic acid (ATRA) (bars 2 and 3, Fig 2) and of Epo (bar 4, Fig 2) to a combination of hemin plus IGF-1 did not alter significantly the number of bursts or of their component colonies observed with hemin and IGF-1 alone. Conversely, if instead of IL-3 hemin was now subtracted from the complete medium, colonies morphologically recognizable as erythroid, and present in comparable numbers, could be observed but they failed to hemoglobinize (bar 9, Fig 2) . However, if IL-3 was also removed, no such recognizable colonies could be seen in the joint presence of Epo, IGF-I, and RA (bar 8, Fig 2) . Therefore, IL-3 appears to be essential for burst formation by PV erythroid progenitors.
A comparison of burst formation from normal and PV PB MNC, grown under optimal conditions in the complete medium (0.25 mmol/L hemin, 0.2 nmoI/t rHu 1L-3, 0.9 nmol/L rHu Epo, 30 nmol/L RA, and plateau concentrations of rHu IGF-1 for each source of assayed cells) indicates that, at this higher and optimal2' concentration of hemin, PV PB MNC displayed a burst-forming capacity slightly but significantly (P < .05) higher than that ofthe normal control (compare bars I , Fig 3) . Moreover, under the mininul SF conditions of hemin and IGF-1 alone, comparable numbcrs of bursts were obtained with both normal and PV circulating MNC (bars 4, Fig 3) , independently of whether R A and Epo were added (bars 2 and 3, Fig 3) . Last, neither hemin by itself nor a combination of IGF-1 plus Epo was capablc of supporting burst formation (bars 5 and 6, Fig 3) , indicating that IGF-1 does not work as a BPA for normal or PV circulating erythroid progenitors. This observation also confirms the need for the addition of differentiation factors like Epo, or IGF-I and RA, when hemin is present, for burst formation to occur.
Erythroid Nature of'Bursts Induced by IL-3 and IGF-l in the Ahsencc. o f Epo
From these data the question arose as to whether the bursts and BCCs produced in vitro under the influence of IL-3 and IGF-1 in the absence of Epo are in fact erythroid in nature, ie, d o their cells contain hemoglobin? Since they were grown in medium containing hemin, the possibility existed that the red color of the cclls in the bursts might result from uptake of hemin from the medium, rather than from hemoglobin synthesized by the cells themselves. T o address this question, we applied a monoclonal antibody directed against human P-globin chains to preparations of cells dissociated from bursts that arose in cultures of PV PB MNC in SF medium containing IL-3 and IGF-l , as well as to those of appropriate controls. The indirect immunofluoresccncc data illustrated in Fig 4 show first that the test for @-globin in the cells ofbursts is specific. They then show that the cells of bursts grown in SF medium in the prescncc of IL-3 and IGF-l contain 8-globin, as do those cultured in the presence of IL-3 and Epo, and that they arc thus fully capable ofundergoing differentiation to hemoglobin-containing erythroid cells, either in thc absence or in the presence of hemin. Throughout the r a t of the work, therefore, we make thc assumption that bursts and BCCs scored in situ on the basis ofthcir orange to red color and distinctive morphology are erythroid in nature.
PV PB MNC' I~~, . v e l~c~.~~~o n . r~~ in SI.' M d i w n
Burst formation by PV PB MNC was titrated as a function of cell conccntration plated in the presence of two concentrations of hemin, 0.1 or 0.25 mmol/L. The relation was found to bc linear in both instances (Fig 5) , and both extrapolated through the origin, indicating that the medium performed satisfactorily for an analysis ofthe growth hctor requirements of PV PB BFU-E. With 0.25 mmol/L of hemin, we obtained an efficiency of 1 burst per l .25O PB MNC plated.
Subtracting rHu Epo from the complete medium had a negligible effect on burst formation by PV PB MNC plated at low cell densities (Fig 6) . Under both conditions, burst number appeared to titrate linearly with cell concentration, within the range of5,000 to 50,000 PB MNC plated per 0.5 mL. A titration ofrHu Epo in the absence of IGF-I scored for the number of bursts produced in our SF medium is shown in Fig 7 (inset) . The dose-response curve is composed of three regions: a basal plateau region, in which the number of bursts is independent of ligand concentration; a proportional region, in which the burst number is related to the ligand concentration; and an upper plateau region, in which the number ofbursts is at a maximum. The response of circulating PV BFU-E was approximately parallel to that observed for normal circulating BFU-E under the same conditions. In the example given, burst-forming efficiency, at plateau values of rHu Epo (20.9 nmol/L), was 1.8 times higher with PV PB MNC than with normal PB MNC, and the number ofbursts observed with PV PB MNC in the absence of Epo was more than double that observed with normal PB MNC (Fig 7 , inset) . However, when these results were expressed as a percentage of the maximum number of bursts obtained at upper plateau rHu Epo concentrations, the relativc sensitivities to rHu Epo on the part of both populations of crythroid progenitors were statistically identical (Fig 7) . The same relationship seen for burst formation was also evident for BCCs from normal and PV PB MNC. Figure 8 shows that in the proportional regions of the curves, the PV and normal were not significantly differ-
.. . Below an Epo concentration of IO"' mol/L (see Figs 7 and 8), in the basal plateau region where burst and BCC formation were independent of the concentration of Epo (and of IGF-1, since no IGF-1 was included in the medium), absolute numbers for the PV curves were significantly higher than those of normal subjects. When normalized as a percentage of maximum, the proportions of PV and normal bursts in the basal plateau region were not significantly different from one another (see Fig 7) , whereas PV BCC formation at the basal plateau represented a higher proportion of the maximum than it did in normal controls (see Fig 8) .
A large number of Epo titrations were performed during the phase of optimization of the SF medium. In these titrations, which were performed in the absence of hemin or retinoids, the numbers of bursts and BCCs that developed were low; in order to score them, acid benzidine was required. Later, when hemin and retinoids were included in the medium, scoring was routinely performed without acid benzidine. However, during the period of SF medium development, as later with the complete medium, no significant differences in sensitivity to Epo by PV and normal erythroid progenitors were detected.
rHu IGF-I. We then examined the effect of IGF-I on burst and BCC formation in SF medium by PV circulating erythroid progenitors, in the absence of added Epo. Figure 9 summarizes the data pooled from five PV patients and three normal subjects, relating the number of bursts produced (expressed as a percentage of maximum) to the logarithm of the concentration of rHu IGF-I in the SF medium. Figure  I O shows the same for BCCs of five PV patients and four normal subjects. In both, the PV curve is displaced to the left more than 2 orders of magnitude in relation to the normal response to rHu IGF-I. The IGF-I ED5, for PV patients lay at 50 pmol/L and for the normal subjects at 8 nmol/L. The PV curve reached the upper plateau of activity at 100-to 1,000-fold below the reported physiological level of total IGF-1 ( IO0 to 300 nmol/L) in ~e r u m .~' .~* The number of bursts and BCCs derived from PV PB MNC, expressed as a percentage of maximum, increased proportionately with the logarithm of IGF-1 concentration, between 3 pmol/L and 3 nmol/L (Fig 11) . Moreover, the response of burst formation did not differ significantly from the response to IGF-1 of BCC formation, over a range of 5 log-units of IGF-1 Concentration.
Effect ofAdherent Cell Removal on Burst Formation by Erythroid Progenitors From PV Patients
We have previously reported that our improved SF medium was unable to support burst formation by circulating normal erythroid progenitors when the cell suspensions plated had been depleted of plastic-adherent cells.29 Figure  12 and the inset show a series of results from one normal versus PV (patient no. 4) pair of donors out of three such experiments (patients no. 4 , 6 , and 8), in which BCC formation by normal and PV erythroid progenitors are compared under optimal SF conditions, before and after a simple adherence step designed to remove most monocytes. Before the adherence step, the number of BCC produced by cells of the PV donor was considerably higher than that of normal controls. (Fig 12, compare both cells, while no burst formation could be observed in the con-
trol, PV burst formation displayed the same hypersensitive PT.' response to IGF-I encountered before the adherence step (Fig 12 and inset, open symbols) . In one of the three cases examined, depletion of plastic-adherent cells actually increased significantly the numbers of both bursts and total BCCs (data not shown). Three PV cases showed burst formation after adherent-cell removal. even when the adherence protocol was repeated for another 90 minutes. In contrast, four of four normal adherent cell-depleted PB MNC failed to produce erythroid bursts under the same conditions. To ascertain if the observed IGF-I effect on PV burst formation (patient no. 7) was mediated by type I receptors,434s a monoclonal antibody (dR-3) directed against type I IGF-1 membrane receptors3' was used at a final concentration of 10 pg/mL in optimal SF culture conditions, in the absence of Epo. The results show that aIR-3 abrogated the effect of IGF-I present at near physiological ( 100 nmol/L) and threshold (3 nmol/L) plateau concentrations (compare bars 3 and 5 v bars 4 and 6 , Fig 13) . However, the data in Fig 13 indicate that the background levels of burst formation, ie. where neither Epo nor IGF-1 was present, were unaffected by aIR-3 antibody (compare bars 1 and 2, Fig 13) .
DISCUSSION
A novel SF medium,29 shown to be free of contamination with either BPA-like or Epo-like factors, or with erythropoiesis inhibitors, offered us a unique opportunity to investigate reliably the sensitivities of circulating BFU-E from patients with PV to the recombinant growth factors Epo and IGF-I and to compare them with those from normal individuals, without the complications introduced by SC or serum-contaminated media with their uncontrolled content of growth factors and inhibitors.
To our knowledge, the present work represents the first time that a SF culture method has been used to test both the Epo-hypersensitivity and the Epo-independence hypotheses, which had been proposed to account for the EECs observed in PV. We found that the sensitivities to Epo of PV erythroid progenitors did not differ significantly from those of normal subjects, as judged by bursts and BCCs scored at days 13 to 16 . This observation agrees with the early findings of Golde et who scored erythroid bursts on days 8 and 9 of culture in a SC medium. However, our observation disagrees with the findings of Casadevall et all' in a so-called SF medium: the basal plateau region of their Epo titration curves in PV gave the impression of extreme hypersensitivity to Epo. However, aside from a contaminated albumin and a BPA-containing Epo, their medium also contained low-density lipoproteins as sources of BPA, and the latter are well known to greatly increase sensitivity to E~o .~' What initially appeared to be strong evidence in favor of the Epo-hypersensitivity model for EEC production came from the work of Zanjani et al." They found that an antiEpo antiserum eliminated EECs, and subsequent administration of Epo resulted in a reappearance of erythroid colonies in the same cultures. However, later experiments by others"*14 with antisera directed against highly purified Epo failed to inhibit EEC formation.
Our work suggests that endogenous burst production in PV requires that erythroid progenitors be exposed to a cell proliferation factor, ie, a BPA (eg, IL-3, hemin) and a differentiation-promoting factor, eg, IGF-1 ,29 to which the PV erythroid progenitors are hypersensitive. Given this model, the results reported by Zanjani et all0 could have come about with an Epo-independent rather than an Epohypersensitive erythroid progenitor, if the antiserum raised against the preparation of Epo that was used (from urine of a patient with aplastic anemia) would also neutralize BPA had the latter been a contaminant of the Epo preparation originally used for immunization. Colony production would be inhibited by the antiserum, not because of its antiEpo activity, but because of its anti-BPA activity. The addition of Epo (contaminated with BPA) would then be able to restore endogenous colony production. Another possibility is that the antibody may have had anti-IGF activity. When taken together with the findings that the Epo receptors on PV erythroblasts do not significantly differ in number or or in internalization or dissociation of bound Epo5' from those of normal subjects, our findings provide compelling evidence against the validity of the Epo-hypersensitivity hypothesis.
It is of interest in this regard that Casadevall et ai," although presenting evidence in favor of the Epo-hypersensitivity hypothesis, noted that they could not rule out Epoindependence coupled with hypersensitivity to some other growth factor as the basis for EECs. A similar suggestion was made by Eridani et al.15 In the present work, we demonstrated, for the first time, that erythroid bursts from PV PB MNC could be obtained in SF medium in the complete absence of Epo, as long as IGF-I was present, in parallel to what we have previously reported for normal human burst formation from PB MNC. 29 In contrast to what we found for the Epo dose-response curve, circulating erythroid progenitors from PV patients were far more sensitive to IGF-I in vitro when compared with their normal counterparts (Figs 9, 10, and 12) . The difference we found between PV and normal subjects lay in the proportional region of the IGF-I dose-response curve for burst or BCC formation, which was shifted to the left (ie, showed increased sensitivity) by at least 2 orders of magnitude.
The mechanism of IGF-1 hypersensitivity in PV will be an interesting topic for future research. The fact that a significant diminution in the number of EEBs was found in our SF medium on the administration of an anti-type 1 IGF-I receptor antibody indicates the involvement of this receptor in mediating the observed hypersensitivity to IGF-I. Our data are thus compatible with the notion that the apparent Epo-independence in PV is actually a dependence on another growth factor, IGF-1 which most likely operates when Epo concentrations are In PV, low serum Epo levels are presumably due to the polycythemia itself inhibiting Epo secretion.52 The polycythemia in turn, we believe, is at least in part due to the overproduction of RBCs by IGF-I -hypersensitive erythroid progenitors driven by IGF-1. These observations agree with the tentative conclusions that we reached from a literature survey, which suggested that the experiments leading to the Epo-independence interpretation of the EEC/EEB phenomenon had all used media containing high levels of i n~u l i n , '~"~ whereas those experiments that suggested instead the Epo-hypersensitivity interpretation lacked insulin (or IGFs) in their Thus, since both insulin and IGF-I can bind and activate the type 1 IGF-l receptor (the former with considerably lower affinity than the we can account for endogenous bursts and colonies in PV as follows: erythroid progenitor cells in PV are specifically hypersensitive to IGF-1 and give rise to erythroid bursts and colonies in vitro in the complete absence of Epo, because the action of Epo can be entirely substituted for by IGF- ists that PV erythroid progenitors may be hypersensitive to that growth factor as well, especially as both ligands can interact with the same IGF type I receptor43 (although with different affinities). The relative sensitivities of PV and normal erythroid progenitors to IGF-2 under SF conditions would appear to deserve investigation.
We had previously shown29 that hemin had two effects on erythroid burst production by normal circulating MNC in SF medium: ( 1) in the presence of Epo or IGF-1, a stimulation of hcmoglobinization that allowed the bursts to be detected in situ by their red color; and (2) a BPA-like effect in which the numbers ofcrythroid bursts and their component colonies were increased. Similar effects of hemin were seen in cultures of erythroid progenitors from PV patients. However, hemin was incapable of supporting burst formation on its own; it required the addition of differentiation factors such as Epo or IGF-1 and RA to bring about burst formation.
Endogenous bursts and BCCs, which developed in the absence of Epo or IGF-I , and which are seen as elcvations in the basal plateau region oftheir ligand dose-response curves (Figs X, 9, 10, and 12), may be attributed to the combined actions of 1L-3 or hcmin and RA. In the absence of IGF-l, but in the presence of RA and 0.1 mmol/L of hemin, three of six PV donors (nos. I , 2, 4, 6, 7, and 8) were capablc of producing bursts indepcndcntly of both IGF-I and Epo (data not shown); with the hemin concentration increased to 0.25 mmol/L, all offour cases examined were positive for burst formation.
In the absence of retinoids, circulating BFIJ-E from either normal subjects or PV patients gave rise to Epo-indcpendent erythroid bursts. but only if IGF-I was present in the medium (in addition to the defined BPAs, hemin or IL-3). In the presence ofretinoids, (which have been shown to have a profound effect on the behavior of normal erythroid prog e n i t o r~~'~'~) , t h e basal plateau of endogenous bursts could be equally observed in PV patients as in normal controls in the absence of Epo or IGF-I (Fig 8) .
Overall, we found a substantially greater efficiency of erythroid burst and BCC production by PV than by normal erythroid progenitor cells (Fig 3, bar 1 ; Fig 7, inset; Fig 12) , thus confirming in SF medium the notion of an expanded erythroid progenitor cell compartment in this myeloproliferative disorder, in agreement with earlier findings by a number of investigators in conventional or serum-contaminated media.7.46 IGF-I did not appear to act on PV PB BFU-E indirectly via plastic-adherent cells, since removal of these cells left the IGF-I -hypersensitive response intact (Fig 12) . This is all the more relevant as more than 97% of these adherent cells typically are monocytes, which in PB are mostly inactive, and active macrophages are the major hematopoietic secretors of IGF-I . 27 The results we obtained with adherence-depleted PV PB MNC are in contrast to the situation found for normal burst formation which, under the same conditions, was totally abrogated by a simple adherence step.
Our results obtained in the absence of any BPA (hemin or IL-3), but in the presence of Epo, IGF-1, and RA, showed that Epo or Epo-like activities (eg, IGF-I and RA) are not sufficient for PV burst formation; a BPA is clearly needed under these limiting conditions. IL-3 appeared to be essential for burst production by PV BFU-E in our SF medium (Fig 2) . It has been proposed that adherent cells may contribute a BPA that enhances burst formation by normal erythroid progenitors, either by recruiting them into cycle or by acting as a critical growth maintenance f a~t o r .~~, '~ PV progenitors could have become either independent from or hypersensitive to this factor, which might explain our positive SF results with PV PR MNC after adherent cell removal.
The theoretical possibility exists that erythroid progenitors from different PV patients may be heterogeneous and differ with respect to their responses to Epo versus IGF-I. In our study, erythroid progenitor cells from none ofthe samplcs from four normal individuals whose erythroid progenitor cells were simultaneously assessed for both growth factors showed hypersensitivity to Epo, while the cells of five of five PV patients similarly assessed showed hypersensitivity to IGF-I . Thus, while heterogeneity ofresponse oferythroid progenitors to these ligands among different PV patients remains thcorctically possible, it did not appear to play a significant role in the PV patient population that we sampled.
Our patients fulfilled the criteria for classical PV2 (Table  I) , and their EECs appeared to bc driven, at least in large part, by hypersensitivity to IGF-I . Certain primary erythrocytosis syndromes exist in which progenitor cells also produce a few EECs under undefined culture conditions. These polycythemias clearly belong to categories distinct from that of classical PV. The serum Epo levels in these conditions were found to bc either ele~ated,'"~' normal,'",h2 or dep r e s~e d .~"~~,~~ However, in all of these instances, a feature shared in common was either that the Epo sensitivities of their erythroid progenitor cells were increased4'~'9~60~h2~63.h' For personal use only. on October 23, 2017. by guest www.bloodjournal.org From or that the cells had normal sensitivities to Epo, but their erythroid progenitor cell compartments were e~p a n d e d .~~.~~ The basis for this behavior is unknown, although in at least five cases the condition was inherited in autosomal-dominant f a~h i o n .~~.~~.~~ All of these investigations were performed in SC cultures. Reinvestigation under stringent SF conditions in vitro, coupled with molecular studies49 on receptors, receptor-ligand interactions, and postreceptor signal transduction pathways, should throw new light on this interesting problem.
Recently, a selective hypersensitivity to granulocyte-macrophage colony-stimulating factor (GM-CSF) by hematopoietic progenitor cells in juvenile chronic myelogenous leukemia (JCML) has been demonstrated under SC condit i o n~.~* This constituted the first demonstration of a myeloid leukemia in which hypersensitivity to a specific growth factor appeared to be involved in the pathogenesis of the disease. The hypersensitivity of granulocytic and monocytic progenitors to GM-CSF persisted after the cultures were depleted of adherent cells (although spontaneous proliferation ceased). Our observations were similar: erythroid progenitors among MNC from the PB of PV patients, unlike their normal counterparts, showed persistent IGF-1 hypersensitivity after adherent cell depletion.
On the basis of the present work, it appears that characteristics of the PV clone include hypersensitivity to IGF-l and independence from Epo and from adherent cell activity.
The production of EECs in SC culture by hematopoietic cells from polycythemia patients has been used as a diagnostic test for PV. While not entirely specific, this test has been considered valuable as an adjunct to other diagnostic proced u r e~.~~,~~-~~ However, the mechanism of the EEC/EEB phenomenon was not understood. Our present work in SF culture throws light on the basis for the EEC/EEB phenomenon in showing that erythroid bursts and colonies can be produced in vitro in the absence of Epo if IGF-I is present.
In conventional media, or serum contaminants'' presumably provided the IGF-I (or the insulin) for EEC/ EEB formation. However, in truly SF culture in the absence of IGF-1 or insulin, we found that the qualitative distinction between PV and normal erythroid progenitors disappeared; the mere expression of EEB/EECs under these conditions in vitro thus ceases to be a sufficient criterion for distinguishing between normal and PV burst and colony formation. While the activity of Epo is replaceable by IGF-I for both PV and normal erythroid progenitors, and the sensitivity to Epo on the part of PV and normals is the same, the sensitivity of PV progenitors to IGF-1 is much greater than that of their normal counterparts (Figs 9 and IO) . Thus, it would be interesting to determine whether an examination of the relative sensitivities of erythroid progenitors to IGF-1 under stringent SF conditions could serve as a diagnostic test for PV.
